FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 25,029,354
- Share change
- +1,980,743
- Total reported value
- $113,880,000
- Price per share
- $4.55
- Number of holders
- 51
- Value change
- +$9,086,443
- Number of buys
- 34
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
|
Company |
5%
|
6,076,879
|
$15,084,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
3.6%
|
4,391,885
|
$11,024,000 | — | 31 Dec 2016 | |
| BVF INC/IL |
13F
|
Company |
3.1%
|
3,759,398
|
$9,436,000 | — | 31 Dec 2016 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
2.1%
|
2,615,847
|
$6,566,000 | — | 31 Dec 2016 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$6,208,000 | — | 31 Dec 2016 | |
| Redmile Group, LLC |
13F
|
Company |
1.2%
|
1,419,058
|
$3,562,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
631,995
|
$1,586,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
557,031
|
$1,398,000 | — | 31 Dec 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
250,000
|
$628,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
209,900
|
$527,000 | — | 31 Dec 2016 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.1%
|
123,500
|
$310,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
115,416
|
$289,000 | — | 31 Dec 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.08%
|
93,982
|
$236,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.05%
|
67,239
|
$169,000 | — | 31 Dec 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
58,558
|
$147,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
39,773
|
$100,000 | — | 31 Dec 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
29,510
|
$74,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
27,379
|
$69,000 | — | 31 Dec 2016 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.02%
|
25,000
|
$63,000 | — | 31 Dec 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
24,853
|
$62,000 | — | 31 Dec 2016 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.02%
|
22,716
|
$57,000 | — | 31 Dec 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.02%
|
22,110
|
$55,000 | — | 31 Dec 2016 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
20,000
|
$50,000 | — | 31 Dec 2016 | |
| Creative Planning |
13F
|
Company |
0.01%
|
17,000
|
$43,000 | — | 31 Dec 2016 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.01%
|
15,000
|
$38,000 | — | 31 Dec 2016 | |
| IFP Advisors, Inc |
13F
|
Company |
0.01%
|
12,040
|
$30,000 | — | 31 Dec 2016 | |
| Hochman Cole Investment Advisors, Inc. |
13F
|
Company |
0.01%
|
10,887
|
$27,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0%
|
5,728
|
$14,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
4,596
|
$12,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
4,030
|
$10,000 | — | 31 Dec 2016 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
2,000
|
$5,000 | — | 31 Dec 2016 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,750
|
$4,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
738
|
$2,000 | — | 31 Dec 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
720
|
$1,000 | — | 31 Dec 2016 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Dec 2016 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2017
As of 31 Mar 2017,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,029,354 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, EcoR1 Capital, LLC, Polaris Venture Management Co. V, L.L.C., BVF INC/IL, KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, VANGUARD GROUP INC, MORGAN STANLEY, and 683 Capital Management, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
33
Q1 2017 holders
51
Holder diff
18
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.